论文部分内容阅读
鼻窦癌较少见,占头颈部恶性肿瘤的2—3％。大多数(80％)为上皮样癌。各肿瘤中心经数十年的经验,尚无较佳的治疗方法。所得的5年存活率很少超过25～30％。 1959年Malecki报告采用颅面联合径路治疗筛窦肿瘤延及筛板区的病人。15年以来,本文作者等也采用了这种手术方法,发现对治疗晚期上颌窦、筛窦癌效果较好。经有经验的神经外科及耳鼻喉科的密切协作,可以很安全地进行这种手术。在早期病例;如能全部切除病变及较小的筛板,其效果更好。必要时这种手术径路也可以联合进行眶内容清除术及上颌骨全切除术。
Sinus cancer is rare, accounting for 2-3% of head and neck cancer. The majority (80%) are epithelial carcinomas. The tumor centers after decades of experience, there is no better treatment. The resulting 5-year survival rate rarely exceeds 25 to 30%. 1959 Malecki report using craniofacial approach for the treatment of ethmoid sinus cancer patients extending to the plate area. For 15 years, the author of this article also adopted this surgical method and found that the treatment of late maxillary sinus, ethmoid sinus cancer better. With intensive neurosurgery and otolaryngology, it is safe to carry out this procedure. In the early cases; if the full removal of lesions and smaller sieve plate, the effect is better. If necessary, this surgical approach can also be combined with orbital debridement and maxillary total resection.